ClinConnect ClinConnect Logo
Search / Trial NCT05788614

Retroversion in Reverse Shoulder Arthroplasty

Launched by HOSPITAL UNIVERSITARIO REINA SOFIA DE CORDOBA · Mar 24, 2023

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a type of shoulder surgery called reverse shoulder arthroplasty (RSA) to help people with shoulder osteoarthritis. Specifically, the study aims to find out if using a higher angle of retroversion (which is the backward tilt of the shoulder bone) during surgery can improve how well patients can rotate their arm outward. Participants will be randomly assigned to receive either a 0-degree or a 30-degree angle for their surgery, and their progress will be monitored for two years.

To be eligible for the trial, participants need to be over 60 years old and have primary rotator cuff arthropathy, which means they have wear and tear on the shoulder's muscles and tendons. Unfortunately, those who have had previous shoulder surgeries or have post-traumatic arthropathy (shoulder issues caused by an injury) cannot participate. If you join the trial, you can expect regular check-ups to track your recovery and function over the two years, helping researchers understand which surgery angle might work better for improving shoulder movement.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients \> 60 years
  • primary rotator cuff arthropathy
  • implantation of reverse shoulder arthroplasty
  • Exclusion Criteria:
  • previous surgeries in the shoulder
  • post-traumatic arthropathy

About Hospital Universitario Reina Sofia De Cordoba

Hospital Universitario Reina Sofía de Córdoba is a leading academic medical center in Spain, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its extensive expertise and state-of-the-art facilities to facilitate groundbreaking research across various medical disciplines. The institution is dedicated to improving patient outcomes by fostering collaboration among healthcare professionals, researchers, and academic institutions, ensuring that cutting-edge treatments and therapies are developed and made accessible to patients in need.

Locations

Córdoba, Cordoba, Spain

Patients applied

0 patients applied

Trial Officials

Jose Carlos Minarro, Dr

Principal Investigator

Hospital Universitario Reina Sofía de Córdoba

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials